Condition: Hemoptisis
Interventions: Drug: tranexamic acid; Drug: tranexamic acid
Sponsor: Meir Medical Center
Not yet recruiting - verified December 2011
Feeds
6018 items (6018 unread) in 80 feeds
Acinar Cell Carcinoma
(36 unread)
Acinic Cell Carcinoma
(35 unread)
Adenoid Cystic Carcinoma
(70 unread)
Adrenal Gland Cancer
(400 unread)
Ampulla Of Vater
(24 unread)
Anal Cancer
(295 unread)
Angiosarcoma
(107 unread)
Appendix Cancer
(67 unread)
Bile Duct Cancer
(437 unread)
Brain and CNS
(1372 unread)
Carcinoid
(203 unread)
Endocrine/Neuroendocrine
(413 unread)
Gall Bladder Cancer
(234 unread)
Hemangioendothelioma
(53 unread)
Hepatoblastoma
(37 unread)
Pancreas
(69 unread)
Phyllodes
(19 unread)
PMP and Mucinous Tumors
(19 unread)
Rhabdomyosarcoma
(227 unread)
Sarcoma
(816 unread)
Twitter Pals
(1085 unread)
Trials - Carcinoid (9 unread)
-
The Role of Inhalations of Tranexamic Acid in Patients With Hemoptysis
Posted: December 18th, 2011, 8:00am MST
-
68Ga-DOTATATE PET Scan in Neuroendocrine Cancer
Posted: July 11th, 2011, 8:00am MDT
Condition: Neuroendocrine Carcinoma
Intervention: Drug: 68Ga-DOTATATE PET scan
Sponsor: Vanderbilt University
Recruiting - verified January 2012 -
Pazopanib as Single Agent in Advanced NETs
Posted: January 19th, 2011, 8:00am MST
Condition: Advanced/Metastatic Neuroendocrine Tumors
Intervention: Drug: Pazopanib
Sponsor: Grupo Espanol de Tumores Neuroendocrinos
Recruiting - verified January 2012 -
A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study
Posted: January 5th, 2011, 8:00am MST
Condition: Solid Organ Tumors
Intervention:
Sponsor: Precision Therapeutics
Recruiting - verified January 2012 -
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
Posted: June 30th, 2010, 8:00am MDT
Conditions: Extensive Stage Small Cell Lung Cancer; Hereditary Paraganglioma; Male Breast Cancer; Malignant Paraganglioma; Metastatic Gastrointestinal Carcinoid Tumor; Metastatic Pheochromocytoma; Pancreatic Polypeptide Tumor; Recurrent Breast Cancer; Recurrent Cervical Cancer; Recurrent Endometrial Carcinoma; Recurrent Gastrointestinal Carcinoid Tumor; Recurrent Islet Cell Carcinoma; Recurrent Neuroendocrine Carcinoma of the Skin; Recurrent Non-small Cell Lung Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Ovarian Germ Cell Tumor; Recurrent Pheochromocytoma; Recurrent Prostate Cancer; Recurrent Renal Cell Cancer; Recurrent Small Cell Lung Cancer; Recurrent Uterine Sarcoma; Regional Gastrointestinal Carcinoid Tumor; Regional Pheochromocytoma; Stage III Cervical Cancer; Stage III Endometrial Carcinoma; Stage III Neuroendocrine Carcinoma of the Skin; Stage III Ovarian Epithelial Cancer; Stage III Ovarian Germ Cell Tumor; Stage III Prostate Cancer; Stage III Renal Cell Cancer; Stage III Uterine Sarcoma; Stage IIIA Breast Cancer; Stage IIIA Non-small Cell Lung Cancer; Stage IIIB Breast Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer; Stage IV Endometrial Carcinoma; Stage IV Neuroendocrine Carcinoma of the Skin; Stage IV Non-small Cell Lung Cancer; Stage IV Ovarian Epithelial Cancer; Stage IV Ovarian Germ Cell Tumor; Stage IV Prostate Cancer; Stage IV Renal Cell Cancer; Stage IV Uterine Sarcoma; Stage IVA Cervical Cancer; Stage IVB Cervical Cancer; Thyroid Gland Medullary Carcinoma
Interventions: Drug: temsirolimus; Drug: vinorelbine ditartrate
Sponsors: USC/Norris Comprehensive Cancer Center; Wyeth is now a wholly owned subsidiary of Pfizer
Active, not recruiting - verified February 2012 -
SwissNET - a Registry for Neuroendocrine Tumours in Switzerland
Posted: December 24th, 2009, 8:00am MST
Conditions: Neuroendocrine Tumors; Carcinoid Tumor
Intervention:
Sponsors: University Hospital Inselspital, Berne; Cantonal Hospital of St. Gallen; University Hospital, Basel, Switzerland; University Hospital, Geneva; University of Lausanne Hospitals; University of Zurich; Triemlispital Zurich; Spitalnetz Bern; Ospedale Cantonale Bellinzona
Recruiting - verified January 2012 -
RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe
Posted: May 30th, 2008, 8:00am MDT
Conditions: Carcinoma; Neuroendocrine; Non Functioning Neuroendocrine Tumors/NET; Non Syndromic Neuroendocrine Tumors/NET; Carcinoids; Non Functioning
Intervention: Drug: Everolimus
Sponsor: Novartis Pharmaceuticals
Recruiting - verified January 2012 -
Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
Posted: March 9th, 2007, 8:00am MST
Conditions: Carcinoid Tumor; Acromegaly
Intervention: Drug: Pasireotide
Sponsor: Novartis
Active, not recruiting - verified January 2012 -
Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer
Posted: September 6th, 2006, 8:00am MDT
Conditions: Breast Cancer; Colorectal Cancer; Lung Cancer; Malignant Mesothelioma; Prostate Cancer; Psychosocial Effects of Cancer and Its Treatment; Thymoma and Thymic Carcinoma
Interventions: Other: educational intervention; Procedure: psychosocial assessment and care; Procedure: quality-of-life assessment
Sponsors: Fox Chase Cancer Center; National Cancer Institute (NCI)
Active, not recruiting - verified October 2007